JSMO 2025 is an annual meeting specifically focused on clinical oncology in Japan and in the Asian region. At JSMO 2024, we welcomed over 7,000 participants from 35 countries and regions, with 1,258 abstracts submitted. 74% of the presentations were conducted in English, making the conference truly international and enhancing interaction with global participants. JSMO 2025 will also welcome participants with many cutting-edge abstracts from Asia and around the world!

JSMO 2025 is one of the largest clinical oncology conferences in Asia. At JSMO 2024, we welcomed over 7,000 participants from 35 countries and regions, with 1,258 abstracts submitted. 74% of the presentations were conducted in English, making the conference truly international and enhancing interaction with global participants.